Humasis Financials
205470 Stock | KRW 1,612 18.00 1.10% |
Humasis |
Understanding current and past Humasis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Humasis' financial statements are interrelated, with each one affecting the others. For example, an increase in Humasis' assets may result in an increase in income on the income statement.
Please note, the presentation of Humasis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Humasis' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Humasis' management manipulating its earnings.
Humasis Stock Summary
Humasis competes with LabGenomics, Seegene, Access Bio, Woori Technology, and Mirae Asset. Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. The company was founded in 2000 and is based in Anyang, South Korea. HUMASIS is traded on Korean Securities Dealers Automated Quotations in South Korea.Instrument | Korea Stock View All |
Exchange | KOSDAQ |
ISIN | KR7205470008 |
Business Address | 504, Shinwon Vision |
Sector | Healthcare |
Industry | Health Care Equipment & Supplies |
Benchmark | Dow Jones Industrial |
Website | www.humasis.com |
Phone | 82 31 478 8580 |
Currency | KRW - South Korean Won |
You should never invest in Humasis without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Humasis Stock, because this is throwing your money away. Analyzing the key information contained in Humasis' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Humasis Key Financial Ratios
Humasis' financial ratios allow both analysts and investors to convert raw data from Humasis' financial statements into concise, actionable information that can be used to evaluate the performance of Humasis over time and compare it to other companies across industries.Humasis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Humasis's current stock value. Our valuation model uses many indicators to compare Humasis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Humasis competition to find correlations between indicators driving Humasis's intrinsic value. More Info.Humasis Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The ratio of Return On Equity to Return On Asset for Humasis Co is about 289.59 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Humasis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Humasis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Humasis Systematic Risk
Humasis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Humasis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Humasis correlated with the market. If Beta is less than 0 Humasis generally moves in the opposite direction as compared to the market. If Humasis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Humasis is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Humasis is generally in the same direction as the market. If Beta > 1 Humasis moves generally in the same direction as, but more than the movement of the benchmark.
Humasis March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Humasis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Humasis Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Humasis Co based on widely used predictive technical indicators. In general, we focus on analyzing Humasis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Humasis's daily price indicators and compare them against related drivers.
Information Ratio | (0) | |||
Maximum Drawdown | 20.86 | |||
Value At Risk | (3.85) | |||
Potential Upside | 4.11 |
Complementary Tools for Humasis Stock analysis
When running Humasis' price analysis, check to measure Humasis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humasis is operating at the current time. Most of Humasis' value examination focuses on studying past and present price action to predict the probability of Humasis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humasis' price. Additionally, you may evaluate how the addition of Humasis to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |